KORU Medical develops and commercializes large-volume subcutaneous infusion systems, primarily the FREEDOM Infusion System, which includes syringe drivers, needle sets, and tubing designed for portable, battery-free drug delivery. The company sells its FDA-cleared products to pharmaceutical companies, specialty pharmacies, and home infusion providers through direct sales and medical device distributors, with primary applications in immunoglobulin therapies for immunodeficiency conditions and specialized treatments like generalized myasthenia gravis. Revenue comes from three sources: domestic and international product sales of syringe drivers and consumables, and pharma services including feasibility studies, clinical trials, and non-recurring engineering services that support biopharmaceutical companies in developing and commercializing novel subcutaneous therapies.